While CTLA-4 is responsible for inhibiting the activation of naïve T-cells in the lymph node during the initial immune response, PD-1/PD-L1 and LAG-3 play significant roles in the tumor microenvironment [39]. Here, CTLA4 is linked to neoplasm.